StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Longeveron total assets

Total assets on the balance sheet at the end of each period.

Longeveron's total assets was $15.49M at Jun 30, 2026. For fiscal 2025 it was $10.26M, down 59.9% from the year before. The highest annual figure on record is $42.77M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.26M-59.9%
FY2024Dec 31, 2024$25.56M+111.6%
FY2023Dec 31, 2023$12.08M-55.9%
FY2022Dec 31, 2022$27.41M-35.9%
FY2021Dec 31, 2021$42.77M+362.8%
FY2020Dec 31, 2020$9.24M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.49M-7.5%
Q1 FY2026Mar 31, 2026$21.21M+1.7%
Q4 FY2025Dec 31, 2025$10.26M-59.9%
Q3 FY2025Sep 30, 2025$15.56M-48.0%
Q2 FY2025Jun 30, 2025$16.75M-13.6%
Q1 FY2025Mar 31, 2025$20.85M+115.0%
Q4 FY2024Dec 31, 2024$25.56M+111.6%
Q3 FY2024Sep 30, 2024$29.91M+157.3%
Q2 FY2024Jun 30, 2024$19.39M+13.5%
Q1 FY2024Mar 31, 2024$9.70M-55.5%
Q4 FY2023Dec 31, 2023$12.08M-55.9%
Q3 FY2023Sep 30, 2023$11.63M-67.1%
Q2 FY2023Jun 30, 2023$17.09M-56.4%
Q1 FY2023Mar 31, 2023$21.81M-49.0%
Q4 FY2022Dec 31, 2022$27.41M+1.0%
Q2 FY2022Jun 30, 2022$35.33M+18.3%
Q1 FY2022Mar 31, 2022$39.17M+20.8%
Q4 FY2021Dec 31, 2021$42.77M+362.8%
Q3 FY2021Sep 30, 2021$27.15M–
Q2 FY2021Jun 30, 2021$29.86M–
Q1 FY2021Mar 31, 2021$32.43M–
Q4 FY2020Dec 31, 2020$9.24M–

More Longeveron figures

See a number that looks wrong?